Matthew Winton SEC EDGAR Filings (CIK 0001971400)

SEC EDGAR filings, ownership reports, and insider transactions for Matthew Winton.

Business address
C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA, 02210
Top holdings (ownership)
INZY and CRVO
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Matthew Winton has filed 13 SEC EDGAR filings since 04 Apr 2023

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 19 Nov 2025 17 Nov 2025 001-37942
4 Open Document Open Filing FORM 4 17 Nov 2025 14 Nov 2025 001-37942
4 Open Document Open Filing FORM 4 08 Oct 2025 06 Oct 2025 001-37942
3 Open Document Open Filing FORM 3 08 Oct 2025 06 Oct 2025 001-37942
4 Open Document Open Filing 4 03 Jul 2025 01 Jul 2025 001-39397
4 Open Document Open Filing 4 27 Jun 2025 25 Jun 2025 001-39397
4 Open Document Open Filing 4 02 Apr 2025 31 Mar 2025 001-39397
4 Open Document Open Filing 4 17 Mar 2025 11 Mar 2025 001-39397
4 Open Document Open Filing 4 03 Oct 2024 30 Sep 2024 001-39397
4 Open Document Open Filing 4 03 Apr 2024 28 Mar 2024 001-39397
4 Open Document Open Filing 4 15 Mar 2024 13 Mar 2024 001-39397
4 Open Document Open Filing FORM 4 SUBMISSION 04 Apr 2023 03 Apr 2023 001-39397
3 Open Document Open Filing FORM 3 SUBMISSION 04 Apr 2023 03 Apr 2023 001-39397